Tang Capital Management
6
27M
5
1
0.17
3
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 4 participants. Despite the Tang Capital Management, startups are often financed by ProQuest Investments, Fonds de solidaritu00e9 FTQ, Adams Street Partners. The meaningful sponsors for the fund in investment in the same round are Adams Street Partners, Venrock Healthcare Partners, Tavistock Life Sciences. In the next rounds fund is usually obtained by Next47, Ampersand Capital Partners, Adams Street Partners.
The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013. The top activity for fund was in 2019. This Tang Capital Management works on 21 percentage points more the average amount of lead investments comparing to the other organizations.
We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight MethylGene, RadPharm, Attune Pharmaceuticals. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
We also calculated 5 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 3
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (4)
- Health Care (3)
- Clinical Trials (2)
- Image Recognition (2)
- Medical (2) Show 3 more
- Investments by region
-
- United States (3)
- Canada (1)
- Australia (2)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 0.83
- Avg. company exit year
- 21
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Attune Pharmaceuticals | 23 Jan 2019 | Biotechnology | Early Stage Venture | 23M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.